Effects of fish-oil supplementation on myocardial fatty acids in humans

American Journal of Clinical Nutrition

Volumn 85, Issue 5, 2007, Pages 1222-1228

  Metcalf, Robert G ^a   James, Michael J ^a,b,c   Gibson, Robert A ^b   Edwards, James R M ^a   Stubberfield, John ^a   Stuklis, Robert ^a   Roberts Thomson, Kurt ^a   Young, Glenn D ^a,b   Cleland, Leslie G ^a,b,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c HANSON INSTITUTE   (Australia)

Author keywords

Dietary fats; Fatty acids; Fish oils; Humans; Myocardium; n 3 fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; FISH OIL; LINOLENIC ACID; LINSEED OIL; MEMBRANE PHOSPHOLIPID; OLIVE OIL; OMEGA 3 FATTY ACID; OMEGA 3 FATTY ACID PLUS DOCOSAHEXAENOIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; HEART MUSCLE FIBER MEMBRANE; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE;

EID: 34248361129     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/85.5.1222     Document Type: Article

References (37)

1. Kromhout D, Bosschieter EB, de Lezenne Coulander C. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-9.
2. Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997;336:1046-53.
3. Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA 1998;279:23-8.
4. Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287:1815-21.
5. Dolecek TA, Grandits G. Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 1991;66:205-16.
6. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 1989;334:757-61.
7. de Lorgeril M, Renaud S, Mamelle N, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-9.
8. GISSI Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999;354:447-55.
9. Albert CM, Campos H, Stampfer MJ, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-8.
10. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995;274:1363-7.
11. Harris WS, von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 2004;39:212-20.
12. Harris WS, Sands SA, Windsor SL, et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004;110:1645-9.
13. Cleland LG, Proudman SM, Hall C, et al. A biomarker of n-3 compliance in patients taking fish oil for rheumatoid arthritis. Lipids 2003;38:419-24.
14. James MJ, Ursin VM, Cleland LG. Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids. Am J Clin Nutr 2003;77:1140-5.
15. Metcalf RG, Mantzioris E, Cleland LG, James MJ. A practical approach to increasing intake of n-3 fats: use of novel foods enriched with n-3 fats. Eur J Clin Nutr 2003;57:1605-12.
16. Fletcher RF. Lipids of human myocardium. Lipids 1972;7:728-32.
17. Gudbjarnason S, Oskarsdottir G, Doell B, Hallgrimsson J. Myocardial membrane lipids in relation to cardiovascular disease. Adv Cardiol 1978;25:130-44.
18. Shenolikar I. Fatty acid profile of myocardial lipid in populations consuming different dietary fats. Lipids 1980;15:980-2.
19. Rocquelin G, Guenot L, Justrabo E, Grynberg A, David M. Fatty acid composition of human heart phospholipids: data from 53 biopsy specimens. J Mol Cell Cardiol 1985;17:769-73.
20. Rocquelin G, Guenot L, Astorg PO, David M. Phospholipid content and fatty acid composition of human heart. Lipids 1989;24:775-80.
21. Sexton PT, Sinclair AJ, O'Dea K, Sanigorski AJ, Walsh J. The relationship between linoleic acid level in serum, adipose tissue and myocardium in humans. Asia Pac J Clin Nutr 1995;4:314-8.
22. Drake-Holland AJ, Van der Vusse GJ, Roemen TH, et al. Chronic catecholamine depletion switches myocardium from carbohydrate to lipid utilisation. Cardiovasc Drugs Ther 2001;15:111-7.
23. Sigalet DL, Kneteman NM, Thomson AB. Reduction of nutrient absorption in normal rats by cyclosporine. Transplantation 1992;53:1103-7.
24. Leaf A, Kang JX, Xiao Y-F, Billman GE. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 2003;107:2646-52.
25. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-903.
26. Marangoni F, Angeli MT, Colli S, et al. Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. Biochim Biophys Acta 1993;1210:55-62.
27. Sands SA, Reid KJ, Windsor SL, Harris WS. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 2005;40:343-7.
28. Cleland LG, James MJ, Neumann MA, D'Angelo M, Gibson RA. Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects. Am J Clin Nutr 1992;55:395-9.
29. Solomon SD, Zelenkofske S, McMurray JJ, et al. Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med 2005;352:2581-8.
30. Kang JX, Leaf A. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 1994;91:9886-90.
31. Gudbjarnason S, Hallgrimsson J. Prostaglandins and polyunsaturated fatty acids in heart muscle. Acta Biol Med Germ 1976;35:1069-80.
32. Mantzioris E, James MJ, Gibson RA, Cleland LG. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr 1994;59:1304-9.
33. Mantzioris E, James MJ, Gibson RA, Cleland LG. Differences exist in the relationships between dietary linoleic and alpha-linolenic acids and their respective long-chain metabolites. Am J Clin Nutr 1995;61:320-4.
34. Blank C, Neumann MA, Makrides M, Gibson RA. Optimizing DHA levels in piglets by lowering the linoleic acid to α-linolenic acid ratio. J Lipid Res 2002;43:1537-43.
35. Cleland LG, Gibson RA, Pedler J, James MJ. Paradoxical effect of n-3-containing vegetable oils on long-chain n-3 fatty acids in rat heart. Lipids 2005;40:995-8.
36. Kang JX, Leaf A. Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes. Eur J Pharmacol 1996;297:97-106.
37. Kang JX, Xiao YF, Leaf A. Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 1995;92:3997-4001.